Patient Guide: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 27 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT07260877
Status: 🟢 Enrolling Now
Condition: Cutaneous Lupus Erythematosus (CLE), Systemic Lupus Erythematosus, SLE, SLE (Systemic Lupus), CLE
Phase: Phase II

Find a Study Location Near You

This study is available at 27 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Beverly Hills, California
  • • Clearwater, Florida
  • • DeBary, Florida
  • • And 24 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus - Join Clinical Trial NCTNCT07260877

How to Join This Clinical Trial - NCTNCT07260877

Learn how to participate in this Phase II trial studying an investigational therapy for Cutaneous Lupus Erythematosus (CLE), Systemic Lupus Erythematosus, SLE, SLE (Systemic Lupus), CLE. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Cutaneous Lupus Erythematosus (CLE), Systemic Lupus Erythematosus, SLE, SLE (Systemic Lupus), CLE. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Cutaneous Lupus Erythematosus (CLE), Systemic Lupus Erythematosus, SLE, SLE (Systemic Lupus), CLE
Treatment Being Tested
Investigational treatment
Study Phase
Phase II - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT07260877 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 27 locations. Find a study site near you:

Clinical Research Site

Beverly Hills, California 90211 - United States

Status: RECRUITING

Clinical Research Site

Clearwater, Florida 33765 - United States

Status: RECRUITING

Clinical Research Site

DeBary, Florida 32713 - United States

Status: RECRUITING

Clinical Research Site

Tampa, Florida 33606 - United States

Status: RECRUITING

Clinical Research Site

Saint Joseph, Missouri 64506 - United States

Status: RECRUITING

Clinical Research Site

Fairport, New York 14450 - United States

Status: RECRUITING

Clinical Research Site

Memphis, Tennessee 38119 - United States

Status: RECRUITING

Clinical Research Site

Allen, Texas 75013 - United States

Status: RECRUITING

Clinical Research Site

Arlington, Texas 76012 - United States

Status: RECRUITING

Clinical Research Site

Colleyville, Texas 76034 - United States

Status: RECRUITING

And 17 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this Phase II clinical trial for Cutaneous Lupus Erythematosus (CLE), Systemic Lupus Erythematosus, SLE, SLE (Systemic Lupus), CLE:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation